(19)
(11) EP 2 925 887 A2

(12)

(88) Date of publication A3:
16.10.2014

(43) Date of publication:
07.10.2015 Bulletin 2015/41

(21) Application number: 13826603.6

(22) Date of filing: 22.11.2013
(51) International Patent Classification (IPC): 
C12Q 1/68(2006.01)
(86) International application number:
PCT/IB2013/060326
(87) International publication number:
WO 2014/087294 (12.06.2014 Gazette 2014/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 03.12.2012 US 201261732472 P

(71) Applicant: Koninklijke Philips N.V.
5656 AE Eindhoven (NL)

(72) Inventors:
  • VARADAN, Vinay
    NL-5656 AE Eindhoven (NL)
  • KAMALAKARAN, Sitharthan
    NL-5656 AE Eindhoven (NL)
  • JANEVSKI, Angel
    NL-5656 AE Eindhoven (NL)
  • BANERJEE, Nilanjana
    NL-5656 AE Eindhoven (NL)
  • DIMITROVA, Nevenka
    NL-5656 AE Eindhoven (NL)
  • HARRIS, Lyndsay
    NL-5656 AE Eindhoven (NL)

(74) Representative: Müller, Frank 
Philips International B.V. Intellectual Property & Standards High Tech Campus 5
5656 AE Eindhoven
5656 AE Eindhoven (NL)

   


(54) PREDICTIVE OUTCOME ASSESSMENT FOR CHEMOTHERAPY WITH NEOADJUVANT BEVACIZUMAB